Compare, Analyse Jubilant Pharmova with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT PHARMOVA vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the worlds leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industrys broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 JUBILANT PHARMOVA    MYLAN
EQUITY SHARE DATA
    JUBILANT PHARMOVA
Mar-20
MYLAN
Dec-18
JUBILANT PHARMOVA /
MYLAN
5-Yr Chart
Click to enlarge
High Rs7273,539-   
Low Rs2301,948-   
Sales per share (Unadj.) Rs574.71,628.5-  
Earnings per share (Unadj.) Rs56.444.2-  
Cash flow per share (Unadj.) Rs85.4349.1-  
Dividends per share (Unadj.) Rs5.000-  
Dividend yield (eoy) %1.00-  
Book value per share (Unadj.) Rs351.81,761.7-  
Shares outstanding (eoy) m159.28514.50-   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.81.7 49.4%   
Avg P/E ratio x8.562.0 13.7%  
P/CF ratio (eoy) x5.67.9 71.3%  
Price / Book Value ratio x1.41.6 87.3%  
Dividend payout %8.90-   
Avg Mkt Cap Rs m76,2201,411,538 5.4%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m21,2770-   
Avg. sales/employee Rs ThNM23,938.6-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM650.0-  
INCOME DATA
Net Sales Rs m91,544837,850 10.9%  
Other income Rs m4740-   
Total revenues Rs m92,018837,850 11.0%   
Gross profit Rs m19,124216,805 8.8%  
Depreciation Rs m4,619156,879 2.9%   
Interest Rs m2,87440,298 7.1%   
Profit before tax Rs m12,10519,628 61.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,123-3,123 -100.0%   
Profit after tax Rs m8,98222,751 39.5%  
Gross profit margin %20.925.9 80.7%  
Effective tax rate %25.8-15.9 -162.2%   
Net profit margin %9.82.7 361.3%  
BALANCE SHEET DATA
Current assets Rs m50,383467,855 10.8%   
Current liabilities Rs m26,190341,118 7.7%   
Net working cap to sales %26.415.1 174.7%  
Current ratio x1.91.4 140.3%  
Inventory Days Days784 7.8%  
Debtors Days Days5293 55.3%  
Net fixed assets Rs m72,721162,529 44.7%   
Share capital Rs m159446 35.7%   
"Free" reserves Rs m55,8800-   
Net worth Rs m56,039906,401 6.2%   
Long term debt Rs m37,397978,297 3.8%   
Total assets Rs m123,1042,431,319 5.1%  
Interest coverage x5.21.5 350.5%   
Debt to equity ratio x0.71.1 61.8%  
Sales to assets ratio x0.70.3 215.8%   
Return on assets %9.62.6 371.4%  
Return on equity %16.02.5 638.6%  
Return on capital %16.03.2 504.2%  
Exports to sales %00-   
Imports to sales %14.80-   
Net fx Rs m2,0000-   
CASH FLOW
From Operations Rs m15,429174,105 8.9%  
From Investments Rs m-3,270-89,993 3.6%  
From Financial Activity Rs m-10,504-81,108 13.0%  
Net Cashflow Rs m2,2541,442 156.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 74.35 Rs / USD

Compare JUBILANT PHARMOVA With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare JUBILANT PHARMOVA With: AMRUTANJAN HEALTHCARE  SUVEN LIFE SCIENCES  PHAARMASIA  VENUS REMEDIES  BIOCON   



Today's Market

5 Reasons Why Sensex Ended 873 Points Higher Today(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended on a strong note.

Related Views On News

Jubilant Pharmova Drops 6% on Weak March Quarter Numbers (Views On News)

Jun 8, 2021

Here's a rundown on the latest quarterly results of Jubilant Pharmova.

Krsnaa Diagnostics IPO Opens Tomorrow: Key Points to Consider (Views On News)

Aug 3, 2021

Krsnaa Diagnostics grey market premium is at around Rs 440 from its issue price of Rs 933-954.

Windlas Biotech IPO to Hit the Market on 4 August. Key Points to Know (Views On News)

Jul 31, 2021

Windlas Biotech IPO to open for subscription next week. Price band fixed at Rs 448-460.

Sun Pharma Zooms 10% as June Quarter Earnings Beat Estimates (Views On News)

Jul 30, 2021

Here's a rundown on Sun Pharma's June quarter results.

Glenmark Life Sciences IPO Opens Tomorrow: Few Points to Know Before Applying (Views On News)

Jul 26, 2021

All you need to know about the IPO of Glenmark Life Sciences.

More Views on News

Most Popular

Make Startup Profits from Bluechip Stocks (Profit Hunter)

Jul 21, 2021

A 166-bagger stock can deliver even more gains in this decade.

These Are the Best Stocks to Own (Fast Profits Daily)

Jul 22, 2021

Find out what I think are the best kind on stocks to own in the market.

Cash the Crash in Gas Prices (Fast Profits Daily)

Jul 21, 2021

Get ready to profit from the coming crash in the price of natural gas.

A Trading Hack to Multiply Profits (Fast Profits Daily)

Jul 23, 2021

Use this trading hack and get a big boost in your trading profits.

How to Pick Momentum Stocks (Fast Profits Daily)

Jul 26, 2021

Use my trading momentum strategy to increase your trading profits.

More
-->

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

JUBILANT PHARMOVA SHARE PRICE


Aug 3, 2021 (Close)

TRACK JUBILANT PHARMOVA

  • Track your investment in JUBILANT PHARMOVA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT PHARMOVA

JUBILANT PHARMOVA 5-YR ANALYSIS

COMPARE JUBILANT PHARMOVA WITH

FEATURED VIDEOS

India's Best Drone Stocks

What is the Best Time to Sell a Stock?

What Will Make You Rich Faster: Investing or Trading?

CRISIL v/s CARE Ratings: An Interesting Comparison

More Featured Videos

MARKET STATS